Company Announcements - 2023
Analytica enters into DOCA and completes Asset Sale25 Jul 2023
Analytica announces that following the appointment of Administrators on 13 June 2023, a second meeting of creditors was held on 20 July 2023 where creditors approved a deed of company arrangement (DOCA) proposed by Stratos MedTech Pty Ltd and Stratos MedTech Holdings Pty Ltd.
Analytica Adminstrators Seek Expressions of Interest20 Jun 2023
Analytica Ltd (Administrators Appointed) announces that its voluntary administrators will seek urgent Expressions of Interest for the sale and/or recapitalisation of the business and/or assets of Analytica. EOIs should be submitted to the Administrators by 5.00pm AEST on 4 July 2023.
Analytica Enters Voluntary Administration13 Jun 2023
Analytica Ltd (Administrators appointed) (ASX:ALT) ('Analytica'), announces that voluntary administrators have been appointed to oversee the affairs of Analytica
Resignation of CEO12 May 2023
The Company wishes to announce that Mr Geoff Daly has resigned from his role as CEO of the Company effective today.
Option Expiry Notice5 May 2023
The directors of Analytica wish to advise that the final date for exercising the Company's listed options ASX Code: ALTOB is 5.00pm (AEDT) on 18TH June 2023
Appendix 4C28 Apr 2023
Analytica presents its quarterly cash flow report to 31 March 2023.
Response to ASX Query15 March 2023
Analytica's response to ASX query letter of 8 March 2023.
Half Year Report7 March 2023
Analytica presents its audited half year results to 31 December 2022.
Suspension from Quotation1 March 2023
ASX: "The securities of the following entities will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Wednesday, 1 March 2023, for not lodging the relevant periodic report by the due date."
Appendix 4D - Half Year Report28 February 2023
Analytica presents its Appendix 4D - Half year results to 31 December 2022.
Appendix 4C31 Jan 2023
Analytica presents its quarterly cash flow report to 31 December 2022.